Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wu, Yi‐Long
846  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

RoTBench: A Multi-Level Benchmark for Evaluating the Robust..:

Ye, Junjie ; Wu, Yilong ; Gao, Songyang...
http://arxiv.org/abs/2401.08326.  , 2024
Link: http://arxiv.org/abs/240..
 
?
2

ToolEyes: Fine-Grained Evaluation for Tool Learning Capabil..:

Ye, Junjie ; Li, Guanyu ; Gao, Songyang...
http://arxiv.org/abs/2401.00741.  , 2024
Link: http://arxiv.org/abs/240..
 
?
3

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treat..:

Cho, Byoung Chul ; Lee, Jong Seok ; Wu, Yi-Long...
Journal of Thoracic Oncology, 18 (12) , p. 1731 -1742.  , 2024
Link: http://hdl.handle.net/19..
 
?
4

Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in..:

Verhoek, Andre ; Cheema, Parneet ; Melosky, Barbara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169948/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Brief Report: Durvalumab After Chemoradiotherapy in Unresec..:

Naidoo, Jarushka ; Antonia, Scott ; Wu, Yi-Long...
Naidoo , J , Antonia , S , Wu , Y-L , Cho , B C , Thiyagarajah , P , Mann , H , Newton , M & Faivre-Finn , C 2023 , ' Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-mutant NSCLC: A Post-Hoc Subgroup Analysis from PACIFIC ' , Journal of Thoracic Oncology , vol. 18 , no. 5 , pp. 657-663 . https://doi.org/10.1016/j.jtho.2023.02.009.  , 2023
Link: https://research.manches..
 
?
6

SYK-mediated epithelial cell state is associated with respo..:

Zhou, Ji ; Zhang, Xu-Chao ; Xue, Shan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183461/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Novel systemic therapies in the management of tyrosine kina..:

Li, Yang-Si ; Jie, Guang-Ling ; Wu, Yi-Long
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475243/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Asian Thoracic Oncology Research Group (ATORG) Expert Conse..:

Ahn, Myung-Ju ; Mendoza, Marvin Jonne L ; Pavlakis, Nick...
Clinical Lung Cancer, Vol.23 No.8, pp.670-685.  , 2023
Link: https://hdl.handle.net/1..
 
?
9

Lazertinib Versus Gefitinib as First-Line Treatment in Pati..:

Cho, Byoung Chul ; Ahn, Myung-Ju ; Kang, Jin Hyoung...
Journal of Clinical Oncology, Vol.41 No.26, pp.4208-+.  , 2023
Link: https://hdl.handle.net/1..
 
?
10

Final Overall Survival, Safety, and Quality of Life Results..:

Wu, Yi-Long ; Lu, Shun ; Yang, James Chih-Hsin...
JTO Clinical and Research Reports, Vol.3 No.10, p. 100406.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Plain language summary of the updated results from the CROW..:

Solomon, Benjamin J ; Bauer, Todd M ; K Mok, Tony S...
Future Oncology, Vol.19 No.14, pp.961-973.  , 2023
Link: https://hdl.handle.net/1..
 
?
12

Genome-wide association study of lung adenocarcinoma in Eas..:

Shi, Jianxin ; Shiraishi, Kouya ; Choi, Jiyeon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220065/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Outcomes With Pembrolizumab Monotherapy in Patients With Pr..:

Mansfield, Aaron S ; Herbst, Roy S ; de Castro, Gilberto...
JTO Clinical and Research Reports, Vol.2 No.8, p. 100205.  , 2023
Link: https://hdl.handle.net/1..
 
?
14

SAFFRON-103: a phase 1b study of the safety and efficacy of..:

Zhao, Jun ; Yu, Xinmin ; Huang, Dingzhi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944269/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A ; Chang, Gee-Chen...
JTO Clinical and Research Reports, Vol.4 No.5, p. 100499.  , 2023
Link: https://hdl.handle.net/1..
 
1-15